Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Predatory Publishing: Know the Difference Between a Financial Scheme and Scholarly Dissemination

Carina Stanton  |  Issue: December 2017  |  December 20, 2017

Dr. Bucala is concerned that this preponderance of predatory journals seeking financial gain rather than contributing to scientific advancement can negatively affect the public’s perception of academia and, even more concerning, can negatively affect the scientific process involved in preparing a research study for publication.

“A quality product takes time on the part of authors, reviewers, editors and peer reviewers,” he says. “These are critical steps in the dissemination of a paper, because it is done in a blinded fashion and a relatively unbiased way to provide important feedback to the author so the manuscript can be refined and improved.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The competition can be tough to get published in a preeminent journal, such as A&R, with a strong reputation and history, noting that less than 14% of papers that are submitted are accepted. Rejection can be for many different reasons, not only the merit of the work, but also if the research is too specialized and would be a better fit for a different publication, Dr. Bucala explains.

The bottom line is that “you can’t get a quality product by taking shortcuts,” such as those taken by predatory journals, which he labels a distraction.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“This distraction is our reality,” but we can choose to ignore unsolicited messages or the promise of getting published and protect our work from being wasted in these predatory publications, Dr. Bucala stresses. “Our focus should be on the content and the body of the work, and our measure of publishing success should be the advancement of scientific discourse that serves our patients and advances our field of study. This is not a simple task, but it is a fundamental one.”


Carina Stanton is a freelance science journalist based in Denver.

Reference

  1. Conner-Simons A. How three MIT students fooled the world of scientific journals. MIT News. 2015 Apr 14.

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:Professional TopicsTechnology Tagged with:CareerjournalonlinephysicianPractice ManagementpredatorypublishingrheumatologistrheumatologyscamsolicitationTechnology

Related Articles

    The Third Choice: The Predatory Journal Scam

    February 13, 2020

    “Greetings of the day!” My email account used to be flooded by these cheerful salutations, referring to me as an esteemed colleague or a thought leader. ad goes here:advert-1ADVERTISEMENTSCROLL TO CONTINUEI have to admit: at first, I enjoyed receiving these messages. Normally, when I log into my email account, I’m greeted by messages—punctuated by red,…

    Summer 2021’s Awards, Appointments & Announcements in Rheumatology

    September 14, 2021

    Marian Hannan Celebrated after 10 Years as AC&R Editor-in-Chief By Kelly April Tyrrell This summer, the 10-year tenure of Marian Hannan, MPH, DSc, as editor in chief of Arthritis Care & Research (AC&R), has come to an end. Kelli Allen, PhD, assumed the post on July 1. ad goes here:advert-1ADVERTISEMENTSCROLL TO CONTINUE“Marian has done a…

    Lost and found

    A Look Back at the First Use of Cortisone in Rheumatoid Arthritis

    January 17, 2023

    In 1949, the first description of patients with rheumatoid arthritis (RA) given cortisone sent shockwaves through the medical community, quickly capturing the public imagination as well. The paradigm-shifting report paved the way for the use of cortisone and related drugs in RA and many other medical conditions.1 The following is a discussion of some of…

    Thick Skin & Solid Research: Necessary Ingredients for Publishing Success

    June 1, 2023

    Scientific publishing requires a commitment to clear writing, concise narratives and a willingness to accept feedback. Daniel Solomon, MD, editor-in-chief of Arthritis & Rheumatology, provides insights into his experiences.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences